UPDATE : Saturday, October 12, 2019
5 Korean pharmaceuticals jump into biobetter developing business by Marian Chu 2018-01-08 15:59
SillaJen dismisses allegations against its foreign patents by Lee Han-soo 2018-01-08 14:30
Janssen to test RSV drug for Korean infants by Lee Hye-seon 2018-01-08 14:29
Biogen’s spinal muscular atrophy treatment gains approval in Korea by Marian Chu 2018-01-08 14:27
Takeda’s lung cancer drug designated orphan drug in Korea by Marian Chu 2018-01-08 11:19
Korean pharmaceuticals expect to raise US market share by Lee Han-soo 2018-01-05 17:17
Working style of drug salespersons changed by tougher rules by So Jae-hyeon 2018-01-05 16:03
J&J faces charge for forcing distributors to pay kickbacks to medical staffs by Marian Chu 2018-01-05 15:45
B. Braun Korea sharply cuts catheter prices to improve access by Marian Chu 2018-01-04 14:03
Will Brilinta-Aspirin combo prevent stroke and death? by Lee Hye-seon 2018-01-04 11:48
Novartis’ breast cancer therapy wins FDA breakthrough designation by Marian Chu 2018-01-04 10:44
Regulators okay Abbott Korea’s house dust mite allergy treatment by Lee Han-soo 2018-01-03 17:38
Seegene develops 1st molecular diagnostic reagent using AI by Lee Han-soo 2018-01-03 12:12
Anticoagulant latecomer Lixiana outperforms Pradaxa by So Jae-hyeon 2018-01-03 10:56
Green Cross changes its name to GC Pharma by Lee Han-soo 2018-01-02 16:48
Samsung BioLogics denies accounting fraud allegations by Lee Han-soo 2018-01-02 11:52
Genexine, I-MAB sign $548 million deal to develop cancer drug in China by Marian Chu 2017-12-27 15:30
SNUH’s lab to use Medidata’s clinical cloud platform by Marian Chu 2017-12-22 15:31
Handok to sell Actelion’s hypertension drug Uptravi by Marian Chu 2017-12-22 10:46
C-TRI begins local clinical trial for spinal disease treatment by Marian Chu 2017-12-22 09:49
Back to Top